RAEF US, WElink Energy/CTIEC Sign Agreement to Develop US $1 Billion Renewable Energy Projects

RAEF US, the U.S. subsidiary of RAEF (Real Assets Energy Fund), has signed an agreement with WElink Energy/CTIEC to jointly develop a pipeline of new renewable energy projects totaling US $1 billion in North America.

RAEF has an excellent track record in the investment field of clean energy projects across various technologies worldwide. WElink has an equally strong track record in the construction and financing of renewable energy projects internationally. CTIEC (China Triumph International Engineering Co. Ltd.) is an engineering, design and EPC contractor that serves as the engineering and technical platform of CNBM (China National Building Material Co. Ltd.), whose net assets exceed US $46 billion. CNBM delivers long-term competitive solutions for renewable energy projects.

RAEF US will work alongside WElink/CTIEC to identify and develop attractive opportunities in the North American market for renewable energy projects that would be appropriate for acquisition by U.S. institutional investors. Once a viable project opportunity is identified, WElink/CTIEC will take responsibility for the design, engineering, procurement, supply, construction and financing necessary to deliver a fully operational power plant.

The planned investments will be primarily in photovoltaic (PV) solar and wind power generation but other clean technology opportunities such as biomass and hydro will be considered where attractive.

The two groups believe that this cooperation is an excellent opportunity to create additional value in current and future activities for the partners, and in particular to accelerate the project pipeline and investment program for the renewable energy investment fund currently being jointly managed by RAEF US and LM Capital Group, LLC. The partners look forward to this agreement as an important first step in multiple future collaborations.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.